Payer+Provider's Health System Review
May 1, 2020
Remdesivir can now be administered intravenously by healthcare providers in the U.S. as it undergoes further study.
There are reasons to doubt the stock market’s latest rally, experts say.
President Trump has promised masks for nursing homes and a commission to study quality and safety in the wake of covid-19. Neither will be very helpfu.
New findings from Penn Wharton show that reopening states in June would save jobs but put countless more lives at risk.
A decision on summer school programs will be made by the end of May.
The market is down over 2% after wrapping up its best month in decades.
April 30, 2020
Services revenue continued to show strong growth while iPhone sales slowed.
Sweden has a COVID-19 mortality rate of 256 per million residents, three times higher than neighbor Denmark and six times Norway’s.
“It just became known that the coronavirus tests I took came back positive.”
Here’s a timeline of the ongoing debate over state and local government funding.